EPO and diabetes mellitus: However, blood glucose at the end of the study was higher than expected (Diabetic 31.6 ± 0.7mmol/L and Diabetic + EPO 30.1 ± 1.3 mmol/L) and more typical of severe diabetes with irreparable damage to the pancreatic β cells likely in spite of EPO administration [51,52].